Literature DB >> 23063321

Treatment of hyperacute antibody-mediated lung allograft rejection with eculizumab.

Kyle L Dawson, Amit Parulekar, Harish Seethamraju.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23063321     DOI： 10.1016/j.healun.2012.09.016

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  18 in total

Review 1.  Immunosuppression and allograft rejection following lung transplantation: evidence to date.

Authors:  Gregory I Snell; Glen P Westall; Miranda A Paraskeva
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

2.  Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field.

Authors:  Johann Castañeda-Sanabria; David Hajage; Melisande Le Jouan; Anne Perozziello; Florence Tubach
Journal:  Eur J Clin Pharmacol       Date:  2016-02-26       Impact factor: 2.953

Review 3.  Lung transplantation: a treatment option in end-stage lung disease.

Authors:  Marc Hartert; Omer Senbaklavacin; Bernhard Gohrbandt; Berthold M Fischer; Roland Buhl; Christian-Friedrich Vahld
Journal:  Dtsch Arztebl Int       Date:  2014-02-14       Impact factor: 5.594

4.  Antibody-mediated Rejection in Lung Transplantation.

Authors:  Hrishikesh S Kulkarni; Bradford C Bemiss; Ramsey R Hachem
Journal:  Curr Transplant Rep       Date:  2015-09-30

Review 5.  The role of the immune system in lung transplantation: towards improved long-term results.

Authors:  Ramsey R Hachem
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

Review 6.  Immunosuppression in lung transplantation.

Authors:  Jenna L Scheffert; Kashif Raza
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

Review 7.  New concepts of immune modulation in xenotransplantation.

Authors:  Vikas Satyananda; Hidetaka Hara; Mohamed B Ezzelarab; Carol Phelps; David Ayares; David K C Cooper
Journal:  Transplantation       Date:  2013-12-15       Impact factor: 4.939

Review 8.  The Evolution of Lung Transplant Immunosuppression.

Authors:  Steven Ivulich; Glen Westall; Michael Dooley; Gregory Snell
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

Review 9.  The Complement System and Antibody-Mediated Transplant Rejection.

Authors:  Erik Stites; Moglie Le Quintrec; Joshua M Thurman
Journal:  J Immunol       Date:  2015-12-15       Impact factor: 5.422

10.  The role of C4d deposition in the diagnosis of antibody-mediated rejection after lung transplantation.

Authors:  P R Aguilar; D Carpenter; J Ritter; R D Yusen; C A Witt; D E Byers; T Mohanakumar; D Kreisel; E P Trulock; R R Hachem
Journal:  Am J Transplant       Date:  2017-11-11       Impact factor: 8.086
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.